bèta
Trial Radar AI
Ik help u graag met vragen over gezondheidsaandoeningen, behandelingen en het vinden van klinische studies in uw buurt.
Onze zoekfunctie ondersteunt alleen Engels. Gebruik de Trial Radar AI hierboven om te zoeken en te discussiëren in andere talen, of selecteer hieronder de filters voor aandoening en locatie.
477 resultaten
Toont de 50 beste
 
Status (Standaard)
Nog Niet Rekruterend, Rekruterend, Actief, Niet Rekruterend
×
 
Interventie
GLP-1
×
 
Studietitel
Status
Dieetinzichten en voedingservaringen bij volwassenen op GLP-1-therapie - een onderzoek naar veranderingen in de dieetkwaliteit bij volwassenen op GLP-1-therapie (DINE-GLP1) NCT07313384
Rekruterend
Impact GLP-1 Agonists Following Bariatric NCT06132477
Rekruterend
Efficacy of GLP-1 Receptor Agonists in Treating Upper and Lower Extremity Lymphedema NCT07012642
Rekruterend
GLP-1 RA on Liver OMICS in MASLD NCT06982378
Nog niet rekruterend
Effect of Agonist GLP1 on Adipose Tissue in Patients Undergoing Bariatric Surgery (Maigrir_OT) NCT06278285
Rekruterend
Impact of Glucagon-like Peptide-1 (GLP-1) Analogs on Disease Outcomes in Psoriatic Arthritis: A Pragmatic Randomized Controlled Trial NCT07111494
Nog niet rekruterend
GLP-1 and Hypoglycemia NCT01858896
Actief, niet rekruterend
Effects of GLP-1 Formula on GLP-1 and Glucose Regulation NCT07082062
Rekruterend
Effects of a GLP-1 Formula Drink on Gut Microbiota and Glycemic Control in Prediabetic Individuals NCT07089732
Nog niet rekruterend
People With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 Agonists NCT07207148
Rekruterend
Identifying Changes in Food Behaviors Associated With Beginning GLP-1 Medication NCT06843512
Rekruterend
Effect of GLP-1 on Intestinal Barrier Function in SBS-IF Patients: A Preliminary Exploration. NCT07297238
Nog niet rekruterend
Pelvic Floor Disorder Symptoms in Women Seeking Weight Loss Therapy NCT07175805
Nog niet rekruterend
Behavioral Therapy and GLP-1 Analogue Effects on Binge Eating, Weight, and Coping in Obesity (BETTER-GLP1) NCT07042672
Rekruterend
Impact of GLP-1 Receptor Agonists on Patients With IPMN (IPMN-GLP1RA) NCT07014709
Nog niet rekruterend
Combination Therapy for Alcohol Use Disorder NCT07249554
Nog niet rekruterend
Evaluating the Impact of GLP-1 Receptor Agonists With Total Neoadjuvant Therapy in Rectal Cancer NCT07314528
Nog niet rekruterend
Assess Impact of Poly-L-lactic Acid on GLP1 Subjects NCT07217743
Nog niet rekruterend
GLP1 Analogues and the Risk of Osteoarthritis NCT07360457
Nog niet rekruterend
The Effect of GIP, GLP-1 and GLP-2 in Individuals With Genetically Altered Receptor Function (H-21044858) NCT06194955
Rekruterend
Beta Cell Function in Type 2 Diabetes: Differential Effects of SGLT2 Inhibitors and GLIP-Receptor Agonists NCT07325435
Actief, niet rekruterend
Prolongation of GLP-1 Adherence When Using Continuous Glucose Monitoring NCT06668935
Rekruterend
Bone Metabolism in 12-21 Year Olds Undergoing GLP-1 Receptor Agonist Therapy NCT06903923
Rekruterend
The Effect of Endogenous GLP-1 on Glucagon Secretion in Type 1 Diabetes (EX-HYPO) NCT07373236
Rekruterend
Increased Dietary Protein Intake During GLP-1 Medication Use (in Middle-aged Women With Overweight/Obesity) NCT07480109
Nog niet rekruterend
RESCUE: Discontinuation of GLP-1 NCT07190794
Rekruterend
Investigation of the Evolution of Gastric Emptying by Gastric Ultra Sonography in Patients Treated With GLP-1 Receptor Agonists on a 7 Days Pausing Period. NCT06388213
Nog niet rekruterend
Assess Impact of Microdroplet Hyaluronic Acid Filler on Skin Quality in Patients on Glucagon-like Peptide-1 Agonists NCT07221461
Nog niet rekruterend
Protective Benefits of a Clear Liquid Diet on Residual Gastric Content in Patients Taking Glucagon Like Peptide-1 Receptor (GLP-1 RA) Agonist Prior to Anesthesia NCT06654219
Rekruterend
Effect of Prolonged Fasting Time on Gastric Residual Volume in Patients Taking GLP1 Receptor Agonists NCT07006142
Rekruterend
Beta-cell Response to Incretin Hormones in Cystic Fibrosis NCT01851694
Rekruterend
Effect of GLP-1 Receptor Agonists on Body Composition in Obesity: The Role of Dietary Protein Consumption in Muscle Mass Maintenance (LEAN-PRO GLP-1) NCT07495904
Rekruterend
Ellacor® Micro-Coring Technology® in Fitzpatrick Skin Types I-VI, Including Patients Receiving Glucagon-Like Peptide-1 Receptor Agonists NCT07224880
Rekruterend
Semaglutide and Preoperative Residual Gastric Volumes NCT06263595
Rekruterend
The Impact of GLP Medication on Colonoscopy Bowel Preparation Quality NCT07127354
Rekruterend
PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes (PRECIDENTD) NCT05390892
Rekruterend
The Role of Islet GLP-1 in the Pathogenesis of Prediabetes NCT06967558
Rekruterend
Association of Gene Polymorphism With Susceptibility to T2DM and the Therapeutic Responses to Exenatide in Chinese Patients With T2DM NCT06256419
Rekruterend
Investigating the Impact of GLP-1 RA Therapy on Osteosarcopenia in Older Female Adults With Diabetes (GLOW) NCT07428746
Nog niet rekruterend
Improving Cardiovascular Disease Diagnosis and Treatment in Kazakhstan Using Metabolic Correction With GLP-1 Drugs (ICDDTKZ26) NCT07303556
Actief, niet rekruterend
Effect of a Food for Special Medical Purposes on Muscle Mass Preservation During GLP-1 RAs Weight Loss Treatment (MYO-PRESERVE) NCT07393360
Rekruterend
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery NCT00992901
Rekruterend
Effects of Beginning a GLP1-Agonist Therapy on Residual Gastric Content and Gastric Emptying (GLP-1) NCT06659159
Nog niet rekruterend
Gastric Emptying in Healthy Volunteers and GLP-1 Agonist Users (aGLP1-GUS) NCT06987669
Nog niet rekruterend
Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study (CER-4-T2D) NCT05220917
Actief, niet rekruterend
Insulin-Mediated Glucose Uptake and Organ Perfusion Assessed by Total-Body PET During GIP and GLP-1 Infusion NCT07398300
Rekruterend
Changes in Taste and Eating Habits Associated With GLP-1 Agonists in Weight Loss Patients (GLP1-TASTE) NCT07229170
Nog niet rekruterend
A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs (EXCEED) NCT05663515
Rekruterend
The Effect of rs7903146 Genotype on Islet GLP-1 Production in Humans NCT06972407
Nog niet rekruterend
Restoring Facial Volume After GLP-1 Weight Loss With Radiesse NCT07419854
Rekruterend